Arevipharma Overview
- Year Founded
-
1873
- Status
-
Acquired/Merged
- Employees
-
72
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Arevipharma General Information
Description
Manufacturer of generic and pharmaceutical ingredients intended for the global pharmaceutical industry. The company offers buprenorphine, fentanyl, ketamine, bisoprolol fumarate, carbamazepine, and torasemide, providing pharmaceutical clients with current good manufacturing practice-compliant active ingredients and specialized narcotic handling services to support drug development and production.
Contact Information
Website
www.arevipharma.com(Operating Subsidiary)
Corporate Office
- Meissner Strasse 35
- 01445 Radebeul
- Germany
Corporate Office
- Meissner Strasse 35
- 01445 Radebeul
- Germany
Arevipharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Arevipharma Comparisons
Industry
Financing
Details
Arevipharma Competitors (3)
One of Arevipharma’s 3 competitors is CPL SACHSE, a Corporation company based in Berlin, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CPL SACHSE | Corporation | Berlin, Germany | ||||
| Suanfarma | Private Equity-Backed | Madrid, Spain | ||||
| Procyon Life Sciences | Corporation | Mumbai, India |
Arevipharma Patents
Arevipharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3238849-A1 | Method of making buprenorphine and precursor compounds thereof | Pending | 16-Dec-2021 | ||
| EP-4448501-A1 | Method of making buprenorphine and precursor compounds thereof | Pending | 16-Dec-2021 | ||
| US-20250154160-A1 | Method of making buprenorphine and precursor compounds thereof | Pending | 16-Dec-2021 | ||
| WO-2023111125-A1 | Method of making buprenorphine and precursor compounds thereof | Inactive | 16-Dec-2021 | ||
| EP-3617181-A1 | Synthesis of trans-2-phenylcyclopropylamine or a salt or solvate thereof | Inactive | 30-Aug-2018 | C07C67/14 |
Arevipharma Signals
Arevipharma FAQs
-
When was Arevipharma founded?
Arevipharma was founded in 1873.
-
Where is Arevipharma headquartered?
Arevipharma is headquartered in Radebeul, Germany.
-
What is the size of Arevipharma?
Arevipharma has 72 total employees.
-
What industry is Arevipharma in?
Arevipharma’s primary industry is Pharmaceuticals.
-
Is Arevipharma a private or public company?
Arevipharma is a Private company.
-
What is Arevipharma’s current revenue?
The current revenue for Arevipharma is .
-
Who are Arevipharma’s competitors?
CPL SACHSE, Suanfarma, and Procyon Life Sciences are competitors of Arevipharma.
-
When was Arevipharma acquired?
Arevipharma was acquired on 01-Jan-2021.
-
Who acquired Arevipharma?
Arevipharma was acquired by Yonsung Fine Chemicals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process